Company intelligence / Profile preview

Limbus AI

Regina, Saskatchewan, Canada

Ownership: Private
Development stage: Other

Overview

Limbus AI's flagship commercial product, Limbus Contour, is FDA-cleared and utilizes clinically validated deep learning algorithms to automate and accelerate the contouring process in radiation therapy planning, leading to significantly faster and consistent workflows in cancer treatment planning.[1][2][3][6][7]

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Partnerships

AMG Medtech Ltd (UK/Ireland/Benelux distribution)[1]RefleXion Medical (integration into X1 radiotherapy TPS)[5][6]Accuray (partnership for adaptive radiotherapy solutions)[9]

Beyond the preview

Go deeper on Limbus AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Limbus AI.

Explore the full profile